Cargando…
Concerns with computational protein engineering programmes IPRO and OptMAVEn and metabolic pathway engineering programme optStoic
It has become customary in engineering to require a modelling component in research endeavours. In addition, as the code for these models becomes more byzantine in complexity, it is difficult for reviewers and readers to discern their value and understand the underlying code. This opinion piece summ...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061685/ https://www.ncbi.nlm.nih.gov/pubmed/33529550 http://dx.doi.org/10.1098/rsob.200173 |
_version_ | 1783681617545396224 |
---|---|
author | Wood, Thomas K. |
author_facet | Wood, Thomas K. |
author_sort | Wood, Thomas K. |
collection | PubMed |
description | It has become customary in engineering to require a modelling component in research endeavours. In addition, as the code for these models becomes more byzantine in complexity, it is difficult for reviewers and readers to discern their value and understand the underlying code. This opinion piece summarizes the negative experience of the author with the IPRO and OptMAVEn computational protein engineering models as well as problems with the optStoic metabolic pathway model. In our hands, these models often fail to predict reliable ways to engineer proteins and metabolic pathways. |
format | Online Article Text |
id | pubmed-8061685 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Royal Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-80616852021-05-14 Concerns with computational protein engineering programmes IPRO and OptMAVEn and metabolic pathway engineering programme optStoic Wood, Thomas K. Open Biol Commentary It has become customary in engineering to require a modelling component in research endeavours. In addition, as the code for these models becomes more byzantine in complexity, it is difficult for reviewers and readers to discern their value and understand the underlying code. This opinion piece summarizes the negative experience of the author with the IPRO and OptMAVEn computational protein engineering models as well as problems with the optStoic metabolic pathway model. In our hands, these models often fail to predict reliable ways to engineer proteins and metabolic pathways. The Royal Society 2021-02-03 /pmc/articles/PMC8061685/ /pubmed/33529550 http://dx.doi.org/10.1098/rsob.200173 Text en © 2021 The Authors. https://creativecommons.org/licenses/by/4.0/Published by the Royal Society under the terms of the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, provided the original author and source are credited. |
spellingShingle | Commentary Wood, Thomas K. Concerns with computational protein engineering programmes IPRO and OptMAVEn and metabolic pathway engineering programme optStoic |
title | Concerns with computational protein engineering programmes IPRO and
OptMAVEn and metabolic pathway engineering programme optStoic |
title_full | Concerns with computational protein engineering programmes IPRO and
OptMAVEn and metabolic pathway engineering programme optStoic |
title_fullStr | Concerns with computational protein engineering programmes IPRO and
OptMAVEn and metabolic pathway engineering programme optStoic |
title_full_unstemmed | Concerns with computational protein engineering programmes IPRO and
OptMAVEn and metabolic pathway engineering programme optStoic |
title_short | Concerns with computational protein engineering programmes IPRO and
OptMAVEn and metabolic pathway engineering programme optStoic |
title_sort | concerns with computational protein engineering programmes ipro and
optmaven and metabolic pathway engineering programme optstoic |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8061685/ https://www.ncbi.nlm.nih.gov/pubmed/33529550 http://dx.doi.org/10.1098/rsob.200173 |
work_keys_str_mv | AT woodthomask concernswithcomputationalproteinengineeringprogrammesiproandoptmavenandmetabolicpathwayengineeringprogrammeoptstoic |